Status:
UNKNOWN
Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging
Lead Sponsor:
Nanjing Medical University
Conditions:
Depressive Disorder
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the level of residual symptoms and psychosocial factors affecting recovery of psychosocial functions in MDD patients who reach remission, and investigate the ...
Detailed Description
Objective:At present, clinical remission of depression is defined as a final HAMD score of less than 7. However, in clinical practice, the psychosocial functions of patients who reach remission are fa...
Eligibility Criteria
Inclusion
- Clinical diagnosis of major depressive disorder (MDD)
- Hamilton Rating Scale for Depression(HAMD) less than 7
Exclusion
- Bipolar disorder
- Substance dependence
- Neurological disorder or other mental disorder
- Severe body disease
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01831440
Start Date
January 1 2011
End Date
December 1 2014
Last Update
April 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Brain Hospital
Nanjing, Jiangsu, China, 210029